An electronic system for non-invasive monitoring of estrogen of a female human comprises a wearable device (1) and a processor (13, 30, 40). The wearable device (1) includes a first sensor system (101) configured to be worn in contact with the skin of the female human and to determine a level of perfusion of the female human. The processor (13, 30, 40) is configured to receive and store the level of perfusion of the female human from the first sensor system (101) for a respective point in time. The processor (13, 30, 40) is further configured to determine a change in the level of perfusion of the female human, using the levels of perfusion of the female human stored for a plurality of respective points in time. Furthermore, the processor (13, 30, 40) is configured to detect a change in estrogen level of the female human based on the change in the level of perfusion of the female human.

A method and system are disclosed for determining for a female with irregular menstrual cycles a time interval of fertility, comprising receiving, in a processor (11), from a sensor system (22) of a wearable device (2) of the female, physiological data; determining an estimated time to ovulation of the female, by use of a machine learning model and the physiological data; determining the time interval of fertility using pre-determined time thresholds; and generating a message for the female indicating the time interval of fertility.

A fertility tracking system is disclosed. The system includes a sensual fertility device that provides stimulation to the woman while also providing feedback regarding the status of the user's menstrual cycle in the form of changing colors of the sensual fertility device. The system further includes systemic software (such as a mobile application) that communicates with the sensual fertility device to determine and instruct which color should be activated on the sensual fertility device.

The invention relates to a method for predicting and testing physiological conditions of a female mammal related to an increased level of ferning present in a dried mucous body fluid sample of the female mammal, comprising: capturing an image of the dried mucous body fluid sample via a camera of a mobile telecommunication device through a magnifying lens releasably coupled to an objective of the camera, detecting the presence of crystals in the sample by processing the image, determining the crystal density within the sample from the detected crystals, predicting the physiological condition of the female mammal by comparing the crystal density to reference crystal density data, wherein increased crystal density is indicative of increased ferning level. The invention further relates to a mobile telecommunication device comprising: at least one processing unit, a user input interface, a display, a camera having an objective, a magnifying lens releasably coupled to the objective, at least one memory including computer program code, the at least one memory and the computer program code configured to, with the at least one processing unit, cause the device to perform at least the following: capture an image of a dried mucous body fluid sample of a female mammal via the camera through the magnifying lens, detect the presence of crystals in the sample by processing the image, determine crystal density within the sample from the detected crystals, predict a physiological condition of the female mammal related to an increased level of an ferning by comparing the crystal density to at least one reference density, wherein increased crystal density is indicative of increased ferning level.

An analytical toilet comprising a bowl for receiving excreta from a user; a base supporting the bowl; a supply of flush water; and a plurality of receptacles, each providing mechanical attachment, a power supply, and a data connection to an analytical device, which analytical device is adapted to provide data useful to the user is disclosed.

A health care system includes a server to provide a service to care for a health state of each user, and a terminal of each user. The server registers and manages user information containing at least attribute information of the user, health information, or action information as share information of a group of users in response to an operation from the terminal of the user, checks similarity between the users in the share information, determines a similar user of each of the users, and outputs share information of the similar user of the user to the terminal of the user on the basis of the check information. The health information contains time series data of one element of measurement items containing a body temperature of the user, menstruation, examination results, medication, or symptoms. The action information contains time series data of one of actions or arbitrary texts.

A kit and method for intrauterine insemination is provided. The steps of the method include self-monitoring of a menstrual cycle of a patient by said patient, making an abrasion on the endometrial lining of a uterus of the patient following menstruation by the patient, predicting timing of ovulation by using an ovulation monitoring system or inducing ovulation; preparing sperm for insemination during ovulation by the patient, guiding an intrauterine insemination catheter accompanied by a cervical shield into the patient, depositing a semen sample into the uterine cavity or cervical canal, removing the catheter from the body of the patient while using a holding tool to hold the cervical shield in place at the entrance to the uterine cavity, and leaving the cervical shield in place for a predetermined time period.

An electronic system for non-invasive monitoring of estrogen of a female human comprises a wearable device and a processor. The wearable device includes a first sensor system configured to be worn in contact with the skin of the female human and to determine a level of perfusion of the female human. The processor is configured to receive and store the level of perfusion of the female human from the first sensor system for a respective point in time. The processor is further configured to determine a change in the level of perfusion of the female human, using the levels of perfusion of the female human stored for a plurality of respective points in time. Furthermore, the processor is configured to detect a change in estrogen level of the female human based on the change in the level of perfusion of the female human.

Medical implants including sensors are described. The implant may have a flexible shell with a base, wherein the plurality of sensors may be incorporated onto and/or into the shell. The plurality of sensors may be distributed at different locations of the shell. Each sensor of the plurality of sensors may be configured to measure one or more parameters such as, e.g., temperature and/or pressure, and may comprise an electromagnetic coil useful for wireless transmission of data. Each sensor may be configured to transmit data at a frequency different from the frequency of one or more of the other sensors, may be configured to transmit data at a time different from a time data is transmitted by one or more of the other sensors, and/or may include a device identifier different from the device identifier of one or more of the other sensors.

The present invention relates to a system and methods for evaluating and tracking the operation of the menstrual cycle and treating undesirable trends associated with the menstrual cycle. Various aspects of the system and methods described herein rely upon the operation of diagnostic tests specially configured to evaluate a bodily fluid for the presence or absence of hormones or analytes, and more specifically configured to evaluate a bodily fluid for at least the presence or absence of pregnanediol glucuronide at a threshold selected from the range inclusive of 1 μg/mL-10 μg/mL. The results from one or more diagnostic tests are interpreted in accordance with the teachings of the system. The interpretations are useful in accordance with facilitating treatments associated with medical conditions correlated to the generated interpretations, optionally delivered during a consultation with a medical provider during a telemedicine consultation, the treatments optionally comprising dietary changes incorporating the consumption of certain seeds to mitigate hormonal imbalances.